| Product Name | Anti-Trop2 (sacituzumab govitecan biosimilar) mAb |
|---|---|
| CAS | 1491917-83-9 |
| Storage condition | Store at 4°C, do not freeze |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥5000.00 | Visible after login | |
| 5 mg | 3-5days | ¥22100.00 | Visible after login | |
| 10 mg | 3-5days | ¥38000.00 | Visible after login | |
| 50 mg | 3-5days | ¥152000.00 | Visible after login | |
| 100 mg | 3-5days | ¥275000.00 | Visible after login |
| Product Name | Anti-Trop2 (sacituzumab govitecan biosimilar) mAb |
|---|---|
| CAS | 1491917-83-9 |
| Storage condition | Store at 4°C, do not freeze |
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity.